 |
|
|
| |
Comparison of Serum HBsAg Declines During Tenofovir Disoproxil Fumarate (TDF) Treatment in Different Chronic Hepatitis B (CHB) Patient Populations
|
| |
| |
Reported by Jules Levin
EASL Amsterdam April 24-28 2013
Henry LY Chan1, Maria Buti2, Patrick Marcellin3, Graham R. Foster4, Lanjia Lin5, Benedetta Massetto5, John Flaherty5, Anuj Gaggar5, G. Mani Subramanian5, John McHutchison5, Scott Fung6, Alexander J. Thompson7, Pietro Lampertico8
1Department of Medicine and Therapeutics and Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong; 2Liver Unit, Hospital General Universitari Vall d'Hebron and CIBERehd, Barcelona, Spain; 3Service d'Hépatologie, Hôpital Beaujon, Clichy, and INSERM Unit CRB3, University of Paris, France; 4Queen Mary University of London, London, UK; 5Gilead Sciences, Inc., Foster City, CA, USA; 6Toronto General Hospital, Toronto, Ontario, Canada; 7Gastroenterology Department, St. Vincent's Hospital, Melbourne, Victoria, Australia; 8Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Universita degli Studi di Milano, Milan, Italy
|
| |
|
|
|
|
|
